Cannara Biotech: Funding, Investors & Team (Sep 2026)
For the Quebec and Canadian markets, Cannara Biotech Inc. (TSXV: LOVE) is a vertically integrated producer of premium-grade cannabis and cannabis-derived goods. Delivering "AAAA" products of craft-quality at disruptive retail prices, rotating rare genomes continuously, engaging the community, and being transparent all contribute to the company's value proposition. Cannara owns two enormous facilities in Quebec totaling more than 1,650,000 square feet, taking advantage of the region's affordable labour and electricity costs to produce up to 125,000 kg of cannabis annually.
Cannara Biotech has raised $38.8M across 4 funding rounds on record, the most recent an undisclosed round of $4.6M announced in Feb 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cannara Biotech Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Cannara Biotech Funding Rounds
Cannara Biotech raised $22.0M in a Debt Financing announced in Dec 2021.
1.2 years later, an undisclosed round of $5.0M was announced in Feb 2023.
2.5 years later, an undisclosed round of $7.2M was announced in Aug 2025.
6 months later, an undisclosed round of $4.6M was announced in Feb 2026.
Cannara Biotech Founders and Leadership Team
Contact details for the Cannara Biotech team: 1 of 1 has an email address on file.
Start 14-day free trial →Cannara Biotech Funding Compared to Other Biotechnology Startups
Cannara Biotech's latest round of $4.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cannara Biotech in Biotechnology and Montréal
Companies Similar to Cannara Biotech
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Cannara Biotech Funding FAQs
What does Cannara Biotech do?
For the Quebec and Canadian markets, Cannara Biotech Inc. (TSXV: LOVE) is a vertically integrated producer of premium-grade cannabis and cannabis-derived goods. Delivering "AAAA" products of craft-quality at disruptive retail prices, rotating rare genomes continuously, engaging the community, and being transparent all contribute to the company's value proposition. Cannara owns two enormous facilities in Quebec totaling more than 1,650,000 square feet, taking advantage of the region's affordable labour and electricity costs to produce up to 125,000 kg of cannabis annually.
How much funding has Cannara Biotech raised?
Cannara Biotech has raised $38.8M across 4 rounds on record. The most recent is an undisclosed round of $4.6M announced in Feb 2026.
When did Cannara Biotech last raise funding?
Cannara Biotech's most recent funding round on record is an undisclosed round of $4.6M, announced in Feb 2026.
Who is the CEO of Cannara Biotech?
Zohar Krivorot is listed as CEO at Cannara Biotech.
Where is Cannara Biotech headquartered?
Cannara Biotech is based in Montréal, Quebec, Canada.
How many employees does Cannara Biotech have?
Cannara Biotech is in the 51-100 employee band.
How does Cannara Biotech's funding compare to other Biotechnology startups?
Cannara Biotech's latest round of $4.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Cannara Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cannara Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.